Marc D. Beer
Executive ChairmanMr. Marc D. Beer is Executive Chairman of biote Corp. from June 08, 2026. He serves as Executive Chairman of the Board at Origami Surgical LLC. He has also served as the chairman of the board of Origami Surgical LLC since April 2020. He is the Founder of LumeNXT LLC and has served as its Chairman since August 2018. He serves as Chairman of the Board at Papyrus Therapeutics Inc. since August 2021. He served as the Chief Executive Officer at Aegerion Pharmaceuticals, Inc. from August 19, 2010 to July 27, 2015. He served as the Non Executive Chairman since Spetember 30, 2025 until June 08, 2026 and was Executive Chairman of the Board of directors of biote Corp. since January 2021 until September 30, 2025. He Co-founded Renovia Inc., a leading digital therapeutic company focused on women’s healthcare in August 2016, where he previously held the positions of chairman of the board and chief executive officer and continues to serve as a strategic advisor. Mr. Beer founded ViaCell, Inc. and served as its President and Chief Executive Officer from April 2000 to November 2007. From April 1996 to 2000, he held marketing and business development roles at Genzyme Corporation, Sanofi pharmaceutical company, served as Vice President of Global Marketing. From 1996 to April 2000, he served as Senior Manager at Genzyme Corporation. He also served as Vice President, Global Marketing for Genzyme Therapeutics WorldWide, a division of Genzyme Corporation. He served as Vice President, Sales & Marketing at Biostar, Inc. as well as senior management positions in the Pharmaceutical and Diagnostic divisions of Abbott Laboratories. He has therapeutic development and commercialization experience in biotechnology, pharmaceuticals, device and diagnostics. Mr. Beer has experience in profit and loss management, sales and marketing management and research and development program management in therapeutic, surgical and in vitro diagnostic systems businesses. From November 2007 to August 2010, Mr. Beer served as an independent consultant and Member of the Board of Directors for a number of private life sciences companies. Mr. Beer served as the Founding Chairman of the Board at Minerva Neurosciences, Inc. from December 2013 to January 2018. He served as the Chairman of the Supervisory Board at TxCell Promesses. He served as the Chairman of Good Start Genetics, Inc. He served as the Chairman of Viacell Inc. until January 2004 and its Director since April 2000. He has been a Director of CytoPherx, Inc. since 2001 and Minerva Neurosciences Inc. from December 31, 2013 to 2018. He has been a Director of Seaside Therapeutics LLC since July 2010. Mr. Beer served as a Director of Erytech Pharma Société Anonyme from February 2011 to January 22, 2014 and served as its founding Chairman. He served as a Director at Aegerion Pharmaceuticals, Inc. from August 2010 to July 27, 2015. He is a Member of the Miami University Business Advisory Council and previously a Member of the Notre Dame Research and the Notre Dame Graduate Studies Research and Advisory Council. He served as a Member of Scientific and Medical Advisory Board at TxCell Promesses. He also previously served on the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Body and was a Member of the Mass Life Science Board of the Commonwealth of Massachusetts. Mr. Beer received a Bachelors of Science in Business Administration from Miami University in Ohio.
Positions
- Company Namebiote Corp.Stock CodeBTMDPositionExecutive ChairmanColleagues
- RCRobert C. PetersonInterim CEO, CFO & Chief Business Officer
- JJJohn J. OlsenChief Information Officer
- DMDan MonicoGeneral Counsel
- RKRichard Kevin KeyChief Digital Officer
- CRCory RiceChief Clinical Advisor & Member of Medical Advisory Board
- DJDana JacobyIndependent Director
- ARAndrew Robert HeyerIndependent Director
- DLDebra L. MorrisIndependent Director
